N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma

<p>Abstract</p> <p>Background</p> <p>Correlations of disease phenotypes with glycosylation changes have been analysed intensively in the tumor biology field. Glycoforms potentially associated with carcinogenesis, tumor progression and cancer metastasis have been identif...

Full description

Bibliographic Details
Main Authors: Nakagawa Takahito, Nakanishi Kazuaki, Yokoo Hideki, Kamiyama Naoya, Hamaguchi Jun, Takahashi Masato, Nakagawa Hiroaki, Kudo Takeaki, Kamiyama Toshiya, Deguchi Kisaburo, Nishimura Shin-Ichiro, Todo Satoru
Format: Article
Language:English
Published: BMC 2007-05-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/6/1/32
id doaj-7b87439ec2cf4592bba845c74f3218bd
record_format Article
spelling doaj-7b87439ec2cf4592bba845c74f3218bd2020-11-24T21:52:39ZengBMCMolecular Cancer1476-45982007-05-01613210.1186/1476-4598-6-32N-glycan alterations are associated with drug resistance in human hepatocellular carcinomaNakagawa TakahitoNakanishi KazuakiYokoo HidekiKamiyama NaoyaHamaguchi JunTakahashi MasatoNakagawa HiroakiKudo TakeakiKamiyama ToshiyaDeguchi KisaburoNishimura Shin-IchiroTodo Satoru<p>Abstract</p> <p>Background</p> <p>Correlations of disease phenotypes with glycosylation changes have been analysed intensively in the tumor biology field. Glycoforms potentially associated with carcinogenesis, tumor progression and cancer metastasis have been identified. In cancer therapy, drug resistance is a severe problem, reducing therapeutic effect of drugs and adding to patient suffering. Although multiple mechanisms likely underlie resistance of cancer cells to anticancer drugs, including overexpression of transporters, the relationship of glycans to drug resistance is not well understood.</p> <p>Results</p> <p>We established epirubicin (EPI) – and mitoxantrone (MIT) – resistant cell lines (HLE-EPI and HLE-MIT) from the human hepatocellular carcinoma cell line (HLE). HLE-EPI and HLE-MIT overexpressed transporters MDR1/ABCB1 and BCRP/ABCG2, respectively. Here we compared the glycomics of HLE-EPI and HLE-MIT cells with the parental HLE line. Core fucosylated triantennary oligosaccharides were increased in the two resistant lines. We investigated mRNA levels of glycosyltransferases synthesizing this oligosaccharide, namely, N-acetylglucosaminyltransferase (GnT)-IVa, GnT-IVb and α1,6-fucosyltransferase (α1,6-FucT), and found that α1,6-FucT was particularly overexpressed in HLE-MIT cells. In HLE-EPI cells, GnT-IVa expression was decreased, while GnT-IVb was increased. Both GnT-IVs were downregulated in HLE-MIT cells. HLE-MIT cells also showed decreases in fucosylated tetraantennary oligosaccharide, the product of GnT-V. GnT-V expression was decreased in both lines, but particularly so in HLE-MIT cells. Thus both N-glycan and glycosyltransferase expression was altered as cells acquired tolerance, suggesting novel mechanisms of drug resistance.</p> <p>Conclusion</p> <p>N-glycan and glycosyltransferase expression in HLE-EPI and HLE-MIT were analysed and presented that glycans altered according with acquired tolerance. These results suggested novel mechanisms of drug resistance.</p> http://www.molecular-cancer.com/content/6/1/32
collection DOAJ
language English
format Article
sources DOAJ
author Nakagawa Takahito
Nakanishi Kazuaki
Yokoo Hideki
Kamiyama Naoya
Hamaguchi Jun
Takahashi Masato
Nakagawa Hiroaki
Kudo Takeaki
Kamiyama Toshiya
Deguchi Kisaburo
Nishimura Shin-Ichiro
Todo Satoru
spellingShingle Nakagawa Takahito
Nakanishi Kazuaki
Yokoo Hideki
Kamiyama Naoya
Hamaguchi Jun
Takahashi Masato
Nakagawa Hiroaki
Kudo Takeaki
Kamiyama Toshiya
Deguchi Kisaburo
Nishimura Shin-Ichiro
Todo Satoru
N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
Molecular Cancer
author_facet Nakagawa Takahito
Nakanishi Kazuaki
Yokoo Hideki
Kamiyama Naoya
Hamaguchi Jun
Takahashi Masato
Nakagawa Hiroaki
Kudo Takeaki
Kamiyama Toshiya
Deguchi Kisaburo
Nishimura Shin-Ichiro
Todo Satoru
author_sort Nakagawa Takahito
title N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
title_short N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
title_full N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
title_fullStr N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
title_full_unstemmed N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
title_sort n-glycan alterations are associated with drug resistance in human hepatocellular carcinoma
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2007-05-01
description <p>Abstract</p> <p>Background</p> <p>Correlations of disease phenotypes with glycosylation changes have been analysed intensively in the tumor biology field. Glycoforms potentially associated with carcinogenesis, tumor progression and cancer metastasis have been identified. In cancer therapy, drug resistance is a severe problem, reducing therapeutic effect of drugs and adding to patient suffering. Although multiple mechanisms likely underlie resistance of cancer cells to anticancer drugs, including overexpression of transporters, the relationship of glycans to drug resistance is not well understood.</p> <p>Results</p> <p>We established epirubicin (EPI) – and mitoxantrone (MIT) – resistant cell lines (HLE-EPI and HLE-MIT) from the human hepatocellular carcinoma cell line (HLE). HLE-EPI and HLE-MIT overexpressed transporters MDR1/ABCB1 and BCRP/ABCG2, respectively. Here we compared the glycomics of HLE-EPI and HLE-MIT cells with the parental HLE line. Core fucosylated triantennary oligosaccharides were increased in the two resistant lines. We investigated mRNA levels of glycosyltransferases synthesizing this oligosaccharide, namely, N-acetylglucosaminyltransferase (GnT)-IVa, GnT-IVb and α1,6-fucosyltransferase (α1,6-FucT), and found that α1,6-FucT was particularly overexpressed in HLE-MIT cells. In HLE-EPI cells, GnT-IVa expression was decreased, while GnT-IVb was increased. Both GnT-IVs were downregulated in HLE-MIT cells. HLE-MIT cells also showed decreases in fucosylated tetraantennary oligosaccharide, the product of GnT-V. GnT-V expression was decreased in both lines, but particularly so in HLE-MIT cells. Thus both N-glycan and glycosyltransferase expression was altered as cells acquired tolerance, suggesting novel mechanisms of drug resistance.</p> <p>Conclusion</p> <p>N-glycan and glycosyltransferase expression in HLE-EPI and HLE-MIT were analysed and presented that glycans altered according with acquired tolerance. These results suggested novel mechanisms of drug resistance.</p>
url http://www.molecular-cancer.com/content/6/1/32
work_keys_str_mv AT nakagawatakahito nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT nakanishikazuaki nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT yokoohideki nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT kamiyamanaoya nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT hamaguchijun nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT takahashimasato nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT nakagawahiroaki nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT kudotakeaki nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT kamiyamatoshiya nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT deguchikisaburo nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT nishimurashinichiro nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
AT todosatoru nglycanalterationsareassociatedwithdrugresistanceinhumanhepatocellularcarcinoma
_version_ 1725875568474324992